More NewsRead More
Acquisition Updates, Drug Approval, Drug Development Discontinuation, and Contract Update - Research Reports on AbbVie, Gilead, Pfizer, Lilly and Aetna
October 20, 2014
from PR Newswire
FDA Approves Abuse Deterrent Labeling for EMBEDA® (morphine sulfate and naltrexone hydrochloride) Extended-Release (ER) Capsules CII
October 17, 2014
Lightning Round: Booyah to Pfizer
Today 19:28 EDT
from CNBC.com News
category Mass Business Alliance for Education , Massachusetts Board of Higher Education , IBM , and 22 more.
from Business Journals
Pfizer (PFE) Approaches New Upside Target of $28.20
Today 10:46 EDT
Pfizer’s ‘Head-and-Shoulders’ Top Is a Bad Sign
Today 2:00 EDT
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here